System and method for integrating candidate implant location test results with real-time tissue images for use with implantable device leads

Patent metadata

Field	Value
Publication number	US-9237936-B2
Application number	US-201313940741-A
Country	US
Kind code	B2
Filing date	Jul 12, 2013
Priority date	Jul 12, 2013
Publication date	Jan 19, 2016
Grant date	Jan 19, 2016

Abstract

Patient tissues are imaged using, e.g., a real-time fluoroscopic imaging system, along with a lead system being implanted. Parameters representative of lead placement efficacy—such as capture thresholds, phrenic nerve stimulation thresholds, impedance values or screw-in tip mechanical resistance values—are measured at candidate implant locations. Localization parameters identifying the candidate implant locations are also measured. In one example, a display is generated substantially in real-time showing: images of the tissues of the patient and the lead system being implanted; candidate locations of the electrodes; and parameters representative of lead placement efficacy at the candidate locations. In this manner, the implanting clinician can readily view capture thresholds and other helpful parameters at various candidate locations along with actual real-time images of the tissues of the patient and the lead system being implanted. Recorded images can also be displayed and, in some examples, multiple images can be superimposed over one another.

First claim

What is claimed is:

1. A method for use with an implantable medical lead system for implant within a patient, the method comprising:
imaging tissues of the patient including at least a portion of a lead system being implanted;
measuring at least one parameter representative of lead placement efficacy at at least a first and second candidate implant location within the tissues of the patient using a repositionable electrode of the lead system;
measuring localization parameters identifying the candidate implant locations of the repositionable electrode within a three-dimensional coordinate system; and
generating a display of images of the tissues of the patient and at least a portion of the lead system being implanted, the first candidate location of the repositionable electrode concurrently with the second candidate location of the repositionable electrode, and at least one parameter representative of lead placement efficacy at the candidate locations.

2. The method of claim 1 wherein at least a portion of the images are generated and displayed substantially in real-time.

3. The method of claim 1 wherein imaging the tissues of the patient including at least a portion of a lead system being implanted includes one or more of fluoroscopic imaging, computer aided tomography, ultrasonography, X-ray imaging, nuclear magnetic resonance (NMR) scanning; radioactive imaging; and thermography.

4. The method of claim 1 wherein the measuring at least one parameter representative of lead placement efficacy includes measuring one or more of a myocardial capture threshold, a phrenic nerve stimulation threshold, an electrical impedance between the repositionable electrode of the lead system and another electrode of the lead system, and a mechanical resistance.

5. The method of claim 4 wherein the lead is a screw-in lead and wherein mechanical resistance is determined by measuring a value representative of resistance to insertion of a tip of the lead into patient tissue.

6. The method of claim 5 further including comparing the mechanical resistance to a threshold indicative of scar tissue and generating a warning if the mechanical resistance exceeds the threshold.

7. The method of claim 1 wherein measuring at least one parameter representative of lead placement efficacy is performed by a medical device programmer system based on signals received from the lead system.

8. The method of claim 1 wherein measuring localization parameters identifying the candidate implant location of the repositionable electrode is performed by a medical positioning system (MPS).

9. The method of claim 8 wherein measuring localization parameters identifying the candidate implant locations is performed by the MPS using an electromagnetic field detector coupled to the lead near the repositionable electrode.

10. The method of claim 8 wherein generating the display is performed by the MPS based on images received from an imaging system.

11. The method of claim 1 wherein generating the display includes superimposing a graphical indication of at least one parameter representative of lead placement efficacy for at least one electrode of the lead system at, at least one, candidate implant location onto the images of the tissues of the patient.

12. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes a textual indication of a myocardial capture threshold at the candidate implant locations.

13. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes an indication of whether phrenic nerve stimulation would occur at the candidate implant locations using an electrical stimulation pulse delivered at, at least, the capture threshold.

14. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes an indication of an electrical impedance measured between the electrode at the candidate implant locations and another selected electrode of the system.

15. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes an indication of a mechanical resistance measured during insertion of the repositionable electrode into patient tissue at the candidate implant locations.

16. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes an indication of whether a mechanical resistance measured during insertion of the repositionable electrode into patient tissue exceeds a predetermined scar tissue threshold.

17. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes an indication of a safety distance surrounding the candidate implant locations specifying a minimum safe distance between candidate implant locations of the repositionable electrode.

18. The method of claim 11 wherein the graphical indication of at least one parameter representative of lead placement efficacy includes an indication of a safety distance surrounding the candidate implant location, wherein the safety distance indicates a minimum distance, determined in 3D, from the candidate implant location sufficient to substantially avoid adverse tissue perforation caused by closely spaced implant locations.

19. The method of claim 17 further including generating one or more of a visual or audible warning based on the safety distance.

20. The method of claim 11 wherein the graphical indication is generated based on predetermined thresholds whereby only sites deemed to be acceptable based on the thresholds are highlighted.

21. The method of claim 1 wherein generating the display includes generating a color-coded sensor icon having a color indicating the acceptability of implant parameters at a current location of the sensor icon.

22. The method of claim 1 further including receiving operator input for triggering a display of landmark icons representative of lead placement efficacy parameters at one or more candidate implant locations.

23. The method of claim 1 wherein the measuring at least one parameter representative of lead placement efficacy includes measuring one or more of a myocardial capture threshold, a phrenic nerve stimulation threshold, and a mechanical resistance to active fixation.

24. A system for use with an implantable medical lead system for implant in a patient, the system comprising:
an imaging system operative to image tissues of the patient including at least a portion of a lead system being implanted;
a lead placement efficacy parameter measurement system operative to measure at least one parameter representative of lead placement efficacy at at least a first and second candidate implant location within the tissues of the patient using a repositionable electrode of the lead system;
a candidate implant location parameter measurement system operative to measure localization parameters identifying the candidate implant locations of the repositionable electrode within a three-dimensional coordinate system; and
a candidate implant location display generator configured to generate a display of images of the tissues of the patient and at least a portion of the lead system being implanted, the first candidate location of the repositionable electrode concurrently with at lea

Assignees

• Pacesetter Inc

Inventors

• Razavi Hoda
• Arnold Edith
• Qu Fujian
• Nabutovsky Yelena

Classifications

• A61N1/056

  Transvascular endocardial electrode systems · CPC title

• A61B2019/524

  Human Necessities · mapped topic

• A61B2019/5238

  Human Necessities · mapped topic

• A61B2019/5276

  Human Necessities · mapped topic

• A61B2019/5251

  Human Necessities · mapped topic